Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Portfolio Pulse from Avi Kapoor
Bolt Biotherapeutics shares fell 34% after reporting a GAAP loss of 28 cents per share on $5.30 million in sales. Analysts from Guggenheim and Stifel downgraded the stock. Other stocks like AERWINS Technologies and Sintx Technologies saw significant gains, while Virpax Pharmaceuticals and Yield10 Bioscience experienced notable losses.
May 15, 2024 | 5:38 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bolt Biotherapeutics shares fell 34% after reporting a GAAP loss of 28 cents per share on $5.30 million in sales. Analysts from Guggenheim and Stifel downgraded the stock.
The significant drop in share price is directly linked to the reported financial loss and subsequent analyst downgrades, indicating a negative short-term impact.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Virpax Pharmaceuticals shares fell 63.9% to $0.8199 after the company reported pricing of $2.25m public offering.
The significant drop in share price is likely due to the dilution effect of the public offering, indicating a negative short-term impact.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 50
NEGATIVE IMPACT
Yield10 Bioscience shares fell 49.4% to $2.66 after the company reported delisting from the Nasdaq.
The delisting from Nasdaq is a significant negative event, leading to a sharp decline in share price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
AERWINS Technologies shares surged 201% to $8.16.
The significant surge in share price suggests positive market sentiment, likely driven by recent developments or announcements.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
Sintx Technologies shares jumped 169% to $0.1449 after posting downbeat quarterly results.
Despite downbeat quarterly results, the significant increase in share price indicates positive market reaction, possibly due to other favorable factors.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50